WO2010118873A8 - Vektor für den transport von mikrobiologischen organismen zu krankheitsherden - Google Patents

Vektor für den transport von mikrobiologischen organismen zu krankheitsherden Download PDF

Info

Publication number
WO2010118873A8
WO2010118873A8 PCT/EP2010/002327 EP2010002327W WO2010118873A8 WO 2010118873 A8 WO2010118873 A8 WO 2010118873A8 EP 2010002327 W EP2010002327 W EP 2010002327W WO 2010118873 A8 WO2010118873 A8 WO 2010118873A8
Authority
WO
WIPO (PCT)
Prior art keywords
foci
transporting
vector
disease
microbiological organisms
Prior art date
Application number
PCT/EP2010/002327
Other languages
English (en)
French (fr)
Other versions
WO2010118873A1 (de
Inventor
Ute Steinfeld
Hyeck-Hee Lee
Jong-Oh Park
Ruth Eggers
Original Assignee
Kist-Europe Forschungsgesellschaft Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kist-Europe Forschungsgesellschaft Mbh filed Critical Kist-Europe Forschungsgesellschaft Mbh
Publication of WO2010118873A1 publication Critical patent/WO2010118873A1/de
Publication of WO2010118873A8 publication Critical patent/WO2010118873A8/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/68—Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Die vorliegende Erfindung betrifft einen geschützten und gerichteten Transport von Bakterien bzw. von Bakterien abgeleiteten Wirkstoff in humanen Immunzellen zum Zweck der Therapie und/oder Diagnostik und/oder Theranostik von kranken/degenerierten Geweben (z.B. Krebs).
PCT/EP2010/002327 2009-04-17 2010-04-15 Vektor für den transport von mikrobiologischen organismen zu krankheitsherden WO2010118873A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102009017908A DE102009017908A1 (de) 2009-04-17 2009-04-17 Vektor für den Transport von mikrobiologischen Organismen zu Krankheitsherden
DE102009017908.9 2009-04-17

Publications (2)

Publication Number Publication Date
WO2010118873A1 WO2010118873A1 (de) 2010-10-21
WO2010118873A8 true WO2010118873A8 (de) 2010-12-23

Family

ID=42270186

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/002327 WO2010118873A1 (de) 2009-04-17 2010-04-15 Vektor für den transport von mikrobiologischen organismen zu krankheitsherden

Country Status (2)

Country Link
DE (1) DE102009017908A1 (de)
WO (1) WO2010118873A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012107166B4 (de) * 2012-08-03 2015-04-30 Kist-Europe Forschungsgesellschaft Mbh Transport von photosensibilisierenden Substanzen mit Hilfe lebender Immunzellen zur Tumorbehandlung
CN114432458A (zh) * 2022-01-21 2022-05-06 同济大学 一种细菌载药系统及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344710B2 (en) * 2001-11-21 2008-03-18 The Johns Hopkins University Combination bacteriolytic therapy for the treatment of tumors
US20040208928A1 (en) * 2003-04-15 2004-10-21 Animal Technology Institute Taiwan Method for preparing an orally administrable formulation for controlled release
WO2005039492A2 (en) * 2003-10-22 2005-05-06 The John Hopkins University Improved combination bacteriolytic therapy for the treatment of tumors
US8097245B2 (en) * 2005-12-28 2012-01-17 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
KR101407975B1 (ko) * 2006-05-24 2014-06-17 가부시키가이샤 아네로파마·사이엔스 유전자 수송담체 제작방법
US20100028449A1 (en) * 2006-06-06 2010-02-04 Satya Prakash Fermented milk product and use thereof
CA2933978C (en) * 2007-03-30 2018-08-21 Engeneic Molecular Delivery Pty. Ltd. Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
JP2009213462A (ja) * 2008-02-15 2009-09-24 Kist-Europe Forschungs Gmbh 細胞改変方法および細胞改変装置

Also Published As

Publication number Publication date
DE102009017908A1 (de) 2010-10-21
WO2010118873A1 (de) 2010-10-21

Similar Documents

Publication Publication Date Title
WO2012002760A3 (ko) 세균유래 마이크로베시클을 이용한 암치료 및 암진단 방법
WO2009100137A3 (en) Magnetic cells for localizing delivery and tissue repair
WO2010011404A3 (en) Vectors for delivery of light-sensitive proteins and methods of use
WO2011050302A3 (en) Methods and nutritional formulations to increase the efficacy and reduce the side effects of cancer treatment
WO2012048099A3 (en) Nanoparticle-loaded cells
PH12015500758A1 (en) Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases
GB201309758D0 (en) Generation of neural stem cells from human trophoblast stem cells
WO2009091994A3 (en) Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
MX2013005046A (es) Agentes citotoxicos que comprenden nuevos derivados de ansamitocina.
MX343747B (es) Agentes de union diana contra b7-h1.
MY155454A (en) A pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate
WO2012149549A3 (en) Bacillus bacteria for use in treating and preventing infection in aquatic animals
GB201020032D0 (en) Composition
WO2012003377A3 (en) Methods of preparing chorion tissue and products derived therefrom
MX2015000863A (es) Anticuerpos anti-siglec-15.
WO2012087742A3 (en) Methods and compositions suitable for managing blood glucose in animals
WO2008103920A3 (en) Targeted protein cages
MX341838B (es) Producción de una n-acetilgalactosamina-6-sulfatasa humana activa altamente fosforilada y sus usos.
WO2011130164A3 (en) Unconjugated anti-tfr antibodies and compositions thereof for the treatment of cancer
MY148484A (en) Caspase imaging probes
WO2012048170A3 (en) Humanized animals via tissue engineering and uses therefor
WO2009047568A3 (en) In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
WO2010086838A3 (en) Non-ad5 adenoviral vectors and methods and uses related thereto
WO2008060945A3 (en) Diagnosis and treatment of breast cancer
WO2010135521A3 (en) Compositions and methods for the therapy and diagnosis of influenza

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10715113

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10715113

Country of ref document: EP

Kind code of ref document: A1